MARÍA ESTHER CASTELLANO SÁNCHEZ-rekin lankidetzan egindako argitalpenak (2)

2025

  1. SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 122, Núm. 11

2023

  1. Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma

    Nature Communications, Vol. 14, Núm. 1